For Science Week, we’re hearing from some Irish-based researchers about this year’s theme of regeneration, including Dr Carol ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space.

Healthpeak Properties shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

Vertiv stock shares have risen 175% as of November 11. Last month, the data center hardware and services provider exceeded ...

Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...

Dealmaking this year has been largely muted, but M&A trends are pointing to the areas where pharma is placing the most ...

Diversified Capital Management was previously with Cadaret Grant before it was bought by Atria Wealth (which was subsequently ...

In the Phase 1 trial, VTX3232 exhibited a dose-dependent and dose-linear pharmacokinetic profile with repeat once-daily doses of VTX3232 exceeding ... chronic peripheral inflammatory diseases. IBD ...

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

My NIH-funded research started with a focus on developing advanced chemical biology approaches to understand enzyme/protein ...